Targeting Translation for Treatment of Cancer - A Novel Role for IRES?
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
299-311
Author(s):
Martin Holcik
Drug Delivery Systems for Brain Tumor Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1341-1353
Author(s):
Jarkko Rautioa and Prashant J. Chikhale
Anticancer Agents: Tumor Cell Growth Inhibitory Activity and Binary QSAR Analysis
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1399-1415
Author(s):
Steven S. Ren and Eric J. Lien
Novel Integrin-Specific Targets for Anti-Platelet Therapies
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1603-1609
Author(s):
Aisling Robinson, Sarah O'Neill and Niamh Moran
Linking Inflammation to Cell Cycle Progression
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1653-1666
Author(s):
Gustavo Baldassarre, Milena S. Nicoloso, Monica Schiappacassi, Emanuela Chimienti and Barbara Belletti
Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Journal:
Current Genomics
Volume:
5
Page:
309-325
Author(s):
Raphael Saffroy, Franck Chiappini, Brigitte Debuire and Antoinette Lemoine
Intractable Cancers: The Many Faces of Multidrug Resistance and the Many Targets it Presents for Therapeutic Attack
Journal:
Current Drug Targets
Volume:
5
Page:
333-346
Author(s):
Stein W.D., Bates S.E. and Fojo T.
Cellular Targets for Anticancer Strategies
Journal:
Current Drug Targets
Volume:
5
Page:
347-355
Author(s):
Caterina A.M. La Porta
CARD Proteins as Therapeutic Targets in Cancer
Journal:
Current Drug Targets
Volume:
5
Page:
367-374
Author(s):
Jason S. Damiano and John C. Reed
Sphingolipid Metabolism Enzymes as Targets for Anti-Cancer Therapy
Journal:
Current Drug Targets
Volume:
5
Page:
375-382
Author(s):
J. W. Kok and H. Sietsma